DCT

1:20-cv-00019

Boehringer Ingelheim Pharmaceuticals Inc v. Mylan Pharmaceuticals Inc

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
General
Filed
02/05/20
Cause Of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
Nature of Suit830 Patent
Please sign up or log in to access the advanced features of
Ex Parte Professional.
Judge
Period
PO Win Rate
09/15/21 - now
50%
08/16/21 - 09/15/21
50%
06/15/20 - 08/16/21
50%
Defendant
Please sign up or log in to access the advanced features of
Ex Parte Professional.
Party
No Parties